Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
B
Bobby L. Boyanton
Professor; Pathologist-in-Chief
Also affiliated: Tongji University (2011); Houston Methodist (2007); Arkansas Children's Hospital (2019–2026); Oakland University (2011–2019); Baylor College of Medicine (2004–2008); Beaumont Health (2013–2020); Botsford Hospital (2011–2014); University of Oklahoma Medical Center (2002); Methodist Hospital (2006–2007); Pinnacle Clinical Research (2015); Carolina Ear, Nose and Throat Clinic (2007); Shanghai Pulmonary Hospital (2011); Beaumont Hospital, Royal Oak (2007–2015); Beaumont Hospital, Dearborn (2011–2014); National Hansen's Disease Program (2007); Beaumont Hospital (2017); Texas Children's Hospital (2007–2008); Clinical Research Management (2014); Adult and Pediatric Dermatology (2006); University of Oklahoma Health Sciences Center (2002); University of Rochester (2013); University of Oklahoma (2004)
Faculty Researcher
17 h-index
75 pubs
1,194 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Bobby L. Boyanton's research focuses on infectious diseases, with a particular emphasis on pediatric health and the impact of pathogens on the pharynx. He has investigated the seroprevalence of SARS-CoV-2 in children in Arkansas and explored the association between non-pharmacologic interventions for SARS-CoV-2 and reductions in pediatric infections from *Mycoplasma pneumoniae* and other respiratory viruses. His work also includes examining the mitigation strategies for SARS-CoV-2 and their impact on Group A Streptococcus pharyngitis.
Boyanton's publications also address other significant health concerns, including infective endocarditis caused by *Histoplasma capsulatum* and locally acquired malaria in Arkansas. He has contributed to the understanding of implementing pharmacogenomics testing in a clinical setting, specifically at Arkansas Children’s Hospital. His research network includes frequent collaborations with Joshua L. Kennedy, Ashton Ingold, Dana Frederick, and J. Craig Forrest, all affiliated with the University of Arkansas for Medical Sciences. Boyanton holds an h-index of 16, with 75 total publications and 1,183 citations.
Metrics
- h-index: 17
- Publications: 75
- Citations: 1,194
Selected Publications
-
Photo Quiz: Persistent eyelash debris in a 10-year-old female (2026)
-
Photo Quiz: An infant with cough and lymphocytosis (2026)
-
Photo Quiz: An infant with altered mental status (2026)
-
Photo Quiz: Persistent papules in an immunocompromised child (2026)
-
Photo Quiz: An adolescent male with fever, rash, and polyarthralgia (2026)
-
Photo Quiz: Persistent dysuria and hematuria in a 9-year-old male (2026)
-
Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions (2026)
-
Photo Quiz: A camper with fever, headache, and fatigue (2026)
-
From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma (2025)
-
Genetic characterization of Plasmodium vivax linked to autochthonous malaria transmission in the US (2023) using Illumina AmpliSeq technology: a genetic epidemiology study (2025)
-
Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children (2025)
-
Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps (2024)
-
Review: Known, Emerging, and Remerging Pharyngitis Pathogens (2024)
-
Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers (2024)
-
SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas (2024)
Grants & Funding
As listed on this researcher's institutional profile.
- Antibodies Defining Response to SARS-CoV-2 in Population Exposure Testing NIH/NIAID
- HBV Verification Protocol: Method Comparison – HBV 2.6.3.4.001. Beckman Coulter
- Preoperative Viral Screening As A Tool to Reduce Unexpected Hospital Admissions After Outpatient Surgery. NIH
- Characterization of Pediatric COVID-19 in the Emergency Department of Arkansas Children's Hospital Arkansas Children's Research Institute
- Clinical Method Comparison Study for the NeuMoDx Group B Streptococcus (GBS) Assay on the NeuMoDx Molecular System. NeuMoDx Molecular, Inc.
- Performance Comparison and Workflow Evaluation of Simplexa Bordetella Direct with Illumigene DiaSorin Molecular, LLC
- Developing Reagents to Enable Antibody-Mediated Anti-Viral Therapies against COVID-19 (Dream ATAC) University of Arkansas for Medical Sciences - Time Sensitive Research Award Grant Program
- Respiratory Viral Sequencing and Monitoring NIH/NIGMS
- Simplexa GBS Direct: Clinical Agreement NeuMoDx Molecular, Inc.
- Clinical Validation of the BD MAX™ StaphSR Assay for the Rapid Detection of Staphylococcus aureus (SA) and Methicillin-Resistant Staphylococcus aureus (MRSA) in Nasal Specimens. Becton Dickinson
- Clinical Validation of the Molecular-Based Automated BD MAX Seasonal Respiratory Panel for the Direct, Qualitative Detection of Influenza A, Influenza B, Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) in Nasopharyngeal Swabs from Patients with Signs and Symptoms of Acute Respiratory Illness. Becton Dickinson
- Comparison of Affirm VP-III Test results from standard vaginal collection versus collection from speculum Departments of Pathology & Laboratory Medicine and Family Medicine - Beaumont Health
- 07/2017 Inter-Lab Reproducibility Study, NeuMoDx GBS Test (IUO) on the NeuMoDx Molecular System (IUO). NeuMoDx Molecular, Inc.
- Evaluation of the Quidel Lyra Direct Strep Assay to Detect Group A and Pyogenic Groups C/G Streptococcus from Pharyngeal Specimens. Department of Pathology & Laboratory Medicine - Beaumont Health
Collaboration Network
Top Collaborators
Joshua L. Kennedy
Arkansas Children's Hospital
10 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Implementing Pharmacogenomics Testing: Single Center Experience at Arkansas Children’s Hospital
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Showing 5 of 10 shared publications
Rachel A. Frenner
Arkansas Children's Hospital (US)
6 shared publications
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- SARS-CoV-2 Prevention Measures Concomitantly Attenuate <i>Methicillin-Resistant Staphylococcus aureus</i> Infection Rates
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
Showing 5 of 6 shared publications
Ashton Ingold
University of Arkansas for Medical Sciences
6 shared publications
In database
- SARS-CoV-2 pandemic non-pharmacologic interventions temporally associated with reduced pediatric infections due to <i>Mycoplasma pneumoniae</i> and co-infecting respiratory viruses in Arkansas
- Severe Acute Respiratory Syndrome Coronavirus-2 Lambda Variant Collected from a Child from Arkansas and Sequenced
- SARS-CoV-2 Pandemic Non-Pharmacologic Interventions Temporally Associated with Reduced Pediatric Infections Due to <i>Mycoplasma pneumoniae</i> and Co-Infecting Respiratory Viruses in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
Showing 5 of 6 shared publications
Susanna Hartzell
4 shared publications
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Dana Frederick
University of Arkansas for Medical Sciences
4 shared publications
In database
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- From lockdown to recovery: changing patterns of viral infection severity in a pediatric cohort with asthma
- Hospitalizations and Severity of Rhinovirus-Associated Asthma Exacerbations in Children During the Institution of Non-pharmaceutical Interventions
Karl W. Boehme
Inflammatory Response Research (United States)
3 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
Jessica Snowden
Arkansas Children's Hospital
3 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- SARS-CoV-2 Infection Mitigation Strategies Concomitantly Reduce Group A Streptococcus Pharyngitis
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Catherine Kirkpatrick
Arkansas Children's Hospital
3 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- Seroprevalence of SARS‐CoV‐2 antibodies in front‐line pediatric health care workers
Katherine Caid
University of Arkansas for Medical Sciences (US)
3 shared publications
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
Rachel Frenner
University of Arkansas for Medical Sciences
3 shared publications
In database
- The Presence of Non-pharmaceutical Interventions Correlates with Decreased Rates of Asthma Exacerbations and RSV infections in Arkansas
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
- Resurgence of Respiratory Syncytial Virus Following COVID-19 Pandemic Measures: A Study of Antibody Dynamics in Young Children
Nathan A. Ledeboer
Medical College of Wisconsin (US)
3 shared publications
- Review: Known, Emerging, and Remerging Pharyngitis Pathogens
- Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps
- Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers
John B.H. Caldwell
3 shared publications
- Review: Known, Emerging, and Remerging Pharyngitis Pathogens
- Review: Current Laboratory and Point-of-Care Pharyngitis Diagnostic Testing and Knowledge Gaps
- Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers
Shana M. Owens
University of Arkansas for Medical Sciences
2 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Marianne Kouassi
University of Arkansas for Medical Sciences
2 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Ryan Mann
University of Arkansas for Medical Sciences
2 shared publications
In database
- Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic
- Pediatric SARS-CoV-2 seroprevalence in Arkansas over the first year of the COVID-19 pandemic
Similar Researchers
Based on overlapping research topics
Zain Alamarat
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Stephanie Korff
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Humera Javed
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Rachel Frenner
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Child and Adolescent Health
Hazel Liverett
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Public Health Research
Mojnu Miah
University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
Public Health Research